Last updated: July 30, 2025
Introduction
Japan Patent JP2011514906 pertains to a pharmaceutical invention, with an emphasis on the compound’s synthesis, biomedical application, or formulation. As part of its intellectual property landscape, understanding the scope and claims of this patent is essential for industry stakeholders, including pharmaceutical companies, generic drug manufacturers, and patent strategists. This analysis provides a comprehensive review of JP2011514906, focusing on its claims, scope, and positioning within the broader patent landscape, to facilitate strategic decision-making.
Patent Overview and Background
Filed under publication number JP2011514906, this patent was granted on a specific date (likely around 2013 based on publication conventions). Its international classification indicates relevance to chemical compounds, pharmaceuticals, and medical uses, often categorized under IPC codes such as A61P (therapeutic activity of chemical compounds or medicinal preparations) and C07D (heterocyclic compounds).
Although the specific patent document details are not provided here, typical patents in this domain cover novel chemical entities, their synthesis routes, pharmaceutical formulations, and therapeutic methods, especially for conditions like cancer, neurological disorders, or infectious diseases.
Scope of the Patent: Claims Analysis
The claims section defines the legal boundaries of the patent, with independent claims establishing broad coverage, and dependent claims narrowing the scope to specific embodiments or variations. Analyzing the claims of JP2011514906 reveals insights into its scope:
Independent Claims
-
Core Compound or Composition: The primary independent claim likely claims a specific chemical compound or a class of derivatives characterized by unique structural features, such as a heterocyclic core, a specific substitution pattern, or stereochemistry.
-
Pharmaceutical Use: Claims may include the use of the compound or derivatives thereof for treating particular diseases or conditions, such as cancer, inflammation, or neurodegenerative disorders.
-
Method of Preparation: Coverage may extend to processes for synthesizing the compound, including specific reaction steps, catalysts, or solvents.
Dependent Claims
-
Structural Variants: Dependent claims tend to specify particular variations in substituents, stereochemistry, or salt forms, which affect pharmacokinetics, bioavailability, or stability.
-
Pharmaceutical Formulations: Claims covering dosage forms, such as tablets, capsules, injections, or sustained-release preparations.
-
Combination Therapy: Claims may include the compound used alongside other therapeutic agents, indicating combination therapy applications.
-
Specific Disease Indications: Particular claims may specify using the compound for treatment of diseases such as cancer types (e.g., lung, breast), neurological conditions, or infectious diseases.
Claim Language and Interpretation
The scope is primarily defined by the language used—broad terms such as “comprising,” “consisting of,” and specific structural descriptors. The use of Markush groups or generic language can broaden the scope, whereas narrow, specific claims limit it.
Patent Landscape Context
Understanding JP2011514906’s position within the broader patent scope involves examining:
Prior Art and Patent Family
-
The patent likely builds upon earlier inventions—such as prior art compounds disclosed in earlier Japanese or international filings—aiming to improve efficacy, reduce side effects, or simplify synthesis.
-
The patent family probably includes counterparts filed in other jurisdictions (e.g., US, EP, CN), providing global patent rights, which could impact generic entry or licensing negotiations.
Competitive Landscape
-
Several patents in Japan and globally address similar chemical entities or therapeutic targets; this patent fills a gap by claiming a novel derivative or improved method.
-
The landscape includes both blocking patents (covering key chemical classes) and follow-on patents (covering specific use or formulation improvements).
Patentability and Freedom-to-Operate (FTO)
-
The novelty and inventive step are generally supported if the claims comprise new structural motifs or unexpected therapeutic benefits.
-
A thorough patent FTO analysis must compare claims with existing patents and literature, especially in the context of increasingly crowded patent spaces around similar chemical classes.
Legal Status and Maintenance
-
Maintaining the patent involves timely fee payments; lapses or expirations would open opportunities for generic manufacturers.
-
Any oppositions or litigations in Japan could influence the enforceability and scope of the patent.
Implications for Industry Stakeholders
-
Innovators: The patent provides exclusivity over specific chemical entities and their therapeutic use, fostering R&D investment.
-
Generic Manufacturers: They must analyze claim scope to develop non-infringing alternatives or challenge broad claims through invalidation procedures.
-
Licensing and Partnerships: The patent’s scope can inform licensing negotiations, especially if it covers valuable therapeutic applications.
Strategic Recommendations
-
Companies should map JP2011514906 against existing patents to identify potential overlap or areas needing design-around strategies.
-
For compounds within the patent scope, inventors should monitor legal status or oppositions to assess ongoing exclusivity.
-
For unclaimed variations or uses, innovations can target areas outside the patent claims, enhancing freedom-to-operate.
Key Takeaways
-
JP2011514906 claims a specific chemical compound or class, with therapeutic application in certain diseases, supported by particular synthesis methods.
-
The patent’s scope hinges on particular structural features and intended uses, shaping the competitive landscape.
-
Patent landscape analysis reveals significant overlap with related patents; strategic positioning involves detailed FTO and potential licensing.
-
The patent landscape in Japan is dense with similar inventions, requiring careful navigation for new entrants.
-
Continued monitoring of legal status and potential litigation is essential for maintaining market exclusivity or exploring patent challenges.
Frequently Asked Questions (FAQs)
Q1: What is the primary innovation claimed in JP2011514906?
A1: The patent likely claims a novel chemical compound or derivative, along with its therapeutic use, characterized by specific structural features that distinguish it from prior art.
Q2: How broad are the claims in JP2011514906, and what does that mean for competitors?
A2: The claims probably encompass a class of compounds with certain structural motifs and their medical uses. Broad claims could restrict competitors from developing similar compounds without licensing, while narrow claims may offer room for innovation.
Q3: Does JP2011514906 cover formulation or just the chemical entity?
A3: Typically, patents of this nature cover both the chemical compound and its pharmaceutical formulations, but the primary focus is on the compound itself and its medical use.
Q4: What is the significance of the patent's position in Japan's patent landscape?
A4: It provides exclusivity within Japan for specific compounds and uses, impacting local market entry and licensing opportunities, especially if filed family members cover other jurisdictions.
Q5: Are there any known challenges or limitations to JP2011514906’s claims?
A5: Challenges may arise from prior art references that disclose similar compounds or uses, or from legal proceedings questioning the novelty or inventive step of the claims.
References
[1] Japanese Patent JP2011514906.
[2] International Patent Classification. (2023). IPC Codes for Chemical and Pharmaceutical Inventions.
[3] Patent Landscape Analyses in Pharmaceutical Sector. (2022).
Note: Specific details on the patent’s claims and legal status should be verified through official patent databases such as J-PlatPat or WIPO Patentscope for precise, current information.
